The European Central Bank is challenged by the latest rise in US bond yields on Trump-led reflation expectations. EU rates were not spared from rising global yields, which in turn, have raised doubts over the ECB’s quantitative easing program.
Mirroring the surge in US yields, the EU 10-year bond yield has risen to 0.30 percent on November 15 from 0.19 percent on Nov 8. More importantly, this yield has ceased to be negative since early-October. Over the past week, expectations have increased for fiscal stimulus to overtake monetary policy in supporting growth, DBS reported.
Against this backdrop, the ECB will need to provide clarity on their policy guidance. In the past week, policymakers reiterated their dovish stance to temper the rise in bond yields (and borrowing costs), so not to blunt efforts to stimulate the economy.
Domestic factors continue to support the Eurozone economy. Consumption is benefitting from easing unemployment rates and low inflation. The modestly wider fiscal deficit in 1Q16 may be signaling a let-up in fiscal austerity. However, external factors seem less favorable. Exports and imports extended their declines. Support from exogenous factors such as low oil prices, a weak euro and easy monetary policy are also likely to wane.
"We expect the ECB to keep its rhetoric dovish and announce an extension in the QE purchases at the December meeting. The differentiating factor, however, will be the quantum of purchases, where we now expect a modest cutback," DBS commented in the report.
Meanwhile, a push for more fiscal support will continue, but the precedent of high sovereign debt levels and resultant crisis, raises the hurdle for a looser fiscal policy.


Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
FxWirePro: Daily Commodity Tracker - 21st March, 2022
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Thailand Inflation Remains Negative for 10th Straight Month in January
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 



